These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27930703)

  • 1. The C-Reactive Protein to Albumin Ratio as a Predictor of Severe Side Effects of Adjuvant Chemotherapy in Stage III Colorectal Cancer Patients.
    Tominaga T; Nonaka T; Sumida Y; Hidaka S; Sawai T; Nagayasu T
    PLoS One; 2016; 11(12):e0167967. PubMed ID: 27930703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer.
    Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Shibuya N; Kubota K
    Ann Surg Oncol; 2016 Mar; 23(3):900-7. PubMed ID: 26530445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative C-reactive protein/albumin ratio is a biomarker of risk of recurrence and need for adjuvant chemotherapy for stage III colorectal cancer.
    Matsuoka H; Ando K; Hu Q; Zaitsu Y; Tsuda Y; Hisamatsu Y; Nakashima Y; Kimura Y; Oki E; Mori M
    Int J Clin Oncol; 2020 Jul; 25(7):1318-1326. PubMed ID: 32279124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [C-reactive protein/albumin ratio as a novel inflammation-based prognostic index for predicting outcomes of patients with colorectal cancer].
    Chen YY; Zhang JH; Zhang W; Yang ZK; Luo RC; Kang SJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 May; 37(5):622-627. PubMed ID: 28539284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Significance of the C-Reactive Protein-to-Albumin Ratio in Patients With Metastatic Colorectal Cancer Treated With Trifluridine/Thymidine Phosphorylase Inhibitor as Later-line Chemotherapy.
    Shibutani M; Nagahara H; Fukuoka T; Iseki Y; Matsutani S; Wang EN; Maeda K; Hirakawa K; Ohira M
    Anticancer Res; 2019 Feb; 39(2):1051-1057. PubMed ID: 30711994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer.
    Koike Y; Miki C; Okugawa Y; Yokoe T; Toiyama Y; Tanaka K; Inoue Y; Kusunoki M
    J Surg Oncol; 2008 Dec; 98(7):540-4. PubMed ID: 18937231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The C-reactive protein to albumin ratio predicts postoperative complications in oldest-old patients with colorectal cancer.
    Hashimoto S; Tominaga T; Nonaka T; Hamada K; Araki M; Takeshita H; Fukuoka H; Wada H; To K; Komatsu H; Tanaka K; Sawai T; Nagayasu T
    Int J Colorectal Dis; 2020 Mar; 35(3):423-431. PubMed ID: 31897648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of C-Reactive Protein, Glasgow Prognostic Score, and C-Reactive Protein-to-Albumin Ratio in Colorectal Cancer.
    Zhou J; Wei W; Hou H; Ning S; Li J; Huang B; Liu K; Zhang L
    Front Cell Dev Biol; 2021; 9():637650. PubMed ID: 34765598
    [No Abstract]   [Full Text] [Related]  

  • 9. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma.
    Kinoshita A; Onoda H; Imai N; Iwaku A; Oishi M; Tanaka K; Fushiya N; Koike K; Nishino H; Matsushima M
    Ann Surg Oncol; 2015 Mar; 22(3):803-10. PubMed ID: 25190127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation-based prognostic scores predict disease severity in patients with acute cholecystitis.
    Sato N; Kinoshita A; Imai N; Akasu T; Yokota T; Iwaku A; Koike K; Saruta M
    Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):484-489. PubMed ID: 29303882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin in Patients with Colorectal Cancer.
    Shibutani M; Maeda K; Nagahara H; Iseki Y; Ikeya T; Hirakawa K
    Anticancer Res; 2016 Mar; 36(3):995-1001. PubMed ID: 26976989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of perioperative inflammatory-based prognostic systems in patients with colorectal liver metastases undergoing surgery. A cohort study.
    Solaini L; Atmaja BT; Arumugam P; Hutchins RR; Abraham AT; Bhattacharya S; Kocher HM
    Int J Surg; 2016 Dec; 36(Pt A):8-12. PubMed ID: 27742565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer?
    Rossi S; Basso M; Strippoli A; Schinzari G; D'Argento E; Larocca M; Cassano A; Barone C
    Clin Colorectal Cancer; 2017 Dec; 16(4):264-274. PubMed ID: 28412137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of preoperative C-reactive protein: albumin ratio in patients with clear cell renal cell carcinoma.
    Chen Z; Shao Y; Fan M; Zhuang Q; Wang K; Cao W; Xu X; He X
    Int J Clin Exp Pathol; 2015; 8(11):14893-900. PubMed ID: 26823819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of pretreatment lymphocyte count in stage II colorectal cancer and in high-risk patients treated with adjuvant chemotherapy.
    Liang L; Zhu J; Jia H; Huang L; Li D; Li Q; Li X
    Oncotarget; 2016 Jan; 7(1):1014-28. PubMed ID: 26510910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Inflammation Score in Surgical Patients with Colorectal Cancer.
    Seong MK
    J Korean Med Sci; 2015 Dec; 30(12):1793-9. PubMed ID: 26713054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio.
    Wei XL; Wang FH; Zhang DS; Qiu MZ; Ren C; Jin Y; Zhou YX; Wang DS; He MM; Bai L; Wang F; Luo HY; Li YH; Xu RH
    BMC Cancer; 2015 May; 15():350. PubMed ID: 25934640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ratio of C-reactive protein to albumin is a prognostic factor for operable non-small-cell lung cancer in elderly patients.
    Miyazaki T; Yamasaki N; Tsuchiya T; Matsumoto K; Kunizaki M; Kamohara R; Hatachi G; Doi R; Obata T; Nagayasu T
    Surg Today; 2017 Jul; 47(7):836-843. PubMed ID: 27853867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment C-reactive protein to albumin ratio for predicting overall survival in advanced pancreatic cancer patients.
    Hang J; Xue P; Yang H; Li S; Chen D; Zhu L; Huang W; Ren S; Zhu Y; Wang L
    Sci Rep; 2017 Jun; 7(1):2993. PubMed ID: 28592881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.